Researchers uncover strategy to reduce chemotherapy side effects Blog Post

Researchers at the Institute for Bioengineering of Catalonia (IBEC), based in the Barcelona Science Park, and the Bellvitge Institute for Biomedical Research (IDIBELL) have developed a light-regulated molecule that could improve chemotherapy treatments by controlling the activity of anticancer agents.

 

Fundación GAEM launches its inclusive charity campaign ‘Yo Doy mis Pasos’ Blog Post

GAEM Foundation, headquartered in the Barcelona Science Park, launches its inclusive charity campaign Yo Doy mis Pasos’ [I give my steps], which aims to raise 1 million euros to promote biomedical research in multiple sclerosis, an incurable neurodegenerative disease which affects around 8,000 people in Catalonia and 50,000 in Spain. It is also the second biggest cause of disability in young people in developed countries after road accidents.

 

The Human Protein Atlas will pave the way to personalized medicine Blog Post

World leaders in proteomics are meeting with local doctors and researchers today and tomorrow at CosmoCaixa Barcelona, in an event held by B·Debate, an initiative by Biocat and Obra Social ‘la Caixa’, co-organized in this edition by the Barcelona Science Park (PCB), ProteoRed-ISCIII, Bellvitge Biomedical Research Institute (IDIBELL), Centre for Genomic Regulation (CRG) and Vall d’Hebron Institute of Oncology (VHIO). Four scientists of renowned prestige in this field –including Dr. Eliandre de Oliveira, head of the PCB’s Proteomics Platform– lead this debate.

 

IBEC and IRB Barcelona projects awarded funds from the 2017 edition of La Marató de TV3 Blog Post

Yesterday, La Fundació  Marató de TV3 announced the 36 projects awarded funding in the 2017 edition of the telethon, dedicated to infectious diseases. Among them is a project headed by Ernest Giralt, from the Institute for Research in Biomedicine (IRB Barcelona) and Jordi Vila, from the Barcelona Institute for Global Health (ISGlobal), and two projects led by Xavier Fernandez-Busquets and Antonio Juarez from the Institute for Bioengineering of Catalonia (IBEC).

 

The Structural Biology Unit at IBMB-CSIC received 400.000€ from “La Marató de TV3” 2017 edition Blog Post

F. Xavier Gomis Rüth and Núria Verdaguer, director and Scientific Director respectively of the Structural Biology Unit (SBU) at the Institut de Biologia Molecular de Barcelona (IBMB-CSIC) in the Barcelona Science Park, received the “La Marató” award for their projects on infectious diseases at a ceremony celebrated at the Academy of Medical and Health Sciences of Catalonia and the Balearic Islands.

 

Cebiotex awarded the Cecot Recognition of Innovation prize 2018 Blog Post

Cebiotex– the first spin-off between the SJD Barcelona Children’s Hospital (HSJD) and the Universidad Politécnica de Catalunya (UPC)– awarded the Cecot Recognition of Innovation prize 2018. Joan Bertran, CEO and co-founder of the biotechnology company based at the Barcelona Science Park (Parc Científic de Barcelona, PCB), yesterday received the award at the Cecot Recognition of Business Progress prize-giving ceremony at the National Theatre of Catalonia, as part of the 24th Night of the Entrepreneur, which was chaired by the president of Catalonia, Quim Torra.

 

Researchers from CNAG-CRG and IDIBAPS receive a €8.3 million ERC Synergy Grant Blog Post

The European Research Council (ERC) today announced the results of the 2018 ERC Synergy Grants Call. A project, the BCLL@las, of four research groups from the Centro Nacional de Análisis Genómico (CNAG-CRG) –based in the Barcelona Science Park and integrated into the Centre for Genomic Regulation (CRG)– and the Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) have received this prestigious grant to unravel the genomics and epigenomics of chronic lymphocytic leukemia – the most frequent adult leukemia in the Western world– at unprecedented resolution using single-cell analysis. 

 

Researchers from IBMB-CSIC decipher the first level of DNA folding Blog Post

DNA topology team from the Structural Biology Unit (SBU) of the Institute of Molecular Biology of Barcelona (IBMB-CSIC) at  the Barcelona Science Park has solved the so-called “paradox of the nucleosomal DNA linking number”. They have been able to show that the theory described about how DNA is packaged in our cells was true. The solution to this problem, which has been the subject of debate for more than 3 decades, has been published in the journal Nature Communications.